Characterization of the complete mitochondrial genome data of Asiatic Toad, <i>Bufo gargarizans</i> (Cantor, 1842) (Neobatrachia: Bufonidae) from Mianyang, China. [PDF]
Shan S +5 more
europepmc +1 more source
Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM
ABSTRACT Objective PIGM encodes a critical enzyme in the glycosylphosphatidylinositol (GPI)‐anchor biosynthesis pathway. While promoter‐region mutations in PIGM have been associated with a relatively mild phenotype characterized by portal vein thrombosis and absence seizures, recent evidence suggests that coding‐region mutations result in a more severe
Júlia Sala‐Coromina +11 more
wiley +1 more source
Addressing Unprecedented Uncertainty in Public Health: Advice for Current and Future Leaders. [PDF]
Wykoff R, Petersen DJ.
europepmc +1 more source
Jindong Kim +4 more
openaire +1 more source
ABSTRACT Objective This analysis evaluates the effect of successful reperfusion on functional outcomes after MT, stratified by admission National Institutes of Health Stroke Scale (NIHSS) and Alberta Stroke Program Early CT Score (ASPECTS) as surrogates for clinical‐core mismatch, using multicenter registry data.
Felix Schlicht +53 more
wiley +1 more source
Touch and manual action in chemotherapy-induced peripheral neuropathy: a mixed-methods study. [PDF]
Roberts RD +6 more
europepmc +1 more source
ABSTRACT The Clinical Assessment Scale in Autoimmune Encephalitis (CASE) tracks disease severity in autoimmune encephalitis (AE), but no threshold for significant change exists. We aimed to determine the minimally clinically important difference (MCID) for CASE.
Yihui Goh +8 more
wiley +1 more source
Prevalence and determinants of abortion among married women of reproductive age in rural and urban areas of the Southeastern Zone of Tigray, Ethiopia, 2024 a postwar study. [PDF]
Gebremariam AT +3 more
europepmc +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
Women's perceptions of person-centered comprehensive abortion care and associated factors in Northern Ethiopia: a facility-based cross-sectional study in a humanitarian setting. [PDF]
Amare NS +4 more
europepmc +1 more source

